Reliable detection of Human papillomavirus in recurrent laryngeal papillomatosis and associated carcinoma of archival tissue

Journal of Medical Virology

Volumn 87, Issue 5, 2015, Pages 860-870

  Weiss, Daniel ^a   Heinkele, Thomas ^a   Rudack, Claudia ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

HPV; Recurrent laryngeal papillomatosis; Virus detection

Indexed keywords

BEVACIZUMAB; CIDOFOVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CANCER; LARYNX CARCINOMA; LARYNX PAPILLOMATOSIS; LOW RISK POPULATION; MALE; MIDDLE AGED; NONHUMAN; OVERALL SURVIVAL; PRESCHOOL CHILD; RECURRENT DISEASE; RECURRENT LARYNGEAL PAPILLOMATOSIS; SCHOOL CHILD; VIRUS DETECTION; WART VIRUS; YOUNG ADULT; CARCINOMA; COMPARATIVE STUDY; COMPLICATION; EVALUATION STUDY; ISOLATION AND PURIFICATION; LARYNGEAL NEOPLASMS; MOLECULAR DIAGNOSIS; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; AGED; CARCINOMA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84925091753     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24124     Document Type: Article

References (57)

1. Abramson AL, Steinberg BM, Winkler B. 1987. Laryngeal papillomatosis: Clinical, histopathologic and molecular studies. Laryngoscope 97:678-685.
2. Arikawa E, Sun Y, Wang J, Zhou Q, Ning B, Dial SL, Guo L, Yang J. 2008. Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. BMC Genomics 9:328.
3. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P. 1996. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34:745-747.
4. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. 2005. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11:5694-5699.
5. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen, de Villiers H. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
6. Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, Abramson AL. 2010. Recurrent respiratory papillomatosis: A complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS 118:455-470.
7. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. 2013. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 31:I1-I31.
8. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Myer CM, 3rd, McClay JE, Campisi P, Wiatrak BJ, Sobol SE, Schweinfurth JM, Tsuji DH, Hu FZ, Rockette HE, Ehrlich GD, Post JC. 2008. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One 3:e2263.
9. Cardesa AN, Gale N, Nadal A, Zidar N. 2005. Tumors of the oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours, pathology and genetics of head and neck tumors, 3rd edition. Lyon: IARC Press, pp 118-181.
10. Carvalho CM, Huot L, Charlois AL, Khalfallah SA, Chapuis F, Froehlich P. 2009. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol 129:462-470.
11. Chadha NK, James A. 2012. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev 12:CD005053.
12. Chan PKS, Chan DPC, To KF, Yu MY, Cheung JLK, Cheng AF. 2001. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 54:401-403.
13. Cook JR, Hill DA, Humphrey PA, Pfeifer JD, El-Mofty SK. 2000. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: Emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 13:914-918.
14. Cullen A, Reid R, Campion M, Lörincz A. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65:606-612.
15. De Araujo MR, De Marco L, Santos CF, Rubira-Bullen IR, Ronco G, Pennini I, Vizzini L, Merletti F, Gillio-Tos A. 2009. GP5 +/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus. J Clin Virol 45:90-95.
16. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ. 2007. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11:881-891.
17. Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK, Froehlich P. 2013. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope 123:705-712.
18. De Roda Husman, Walboomers AM, van den Brule JMM, Meijer AJC, Snijders CJLM. 1995. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human Papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
19. Dickens P, Srivastava G, Loke SL, Larkin S. 1991. Human papillomavirus 6, 11 and 16 in laryngeal papillomas. J Pathol 165:243-246.
20. Doeberitz Mv, Vinokurova S. 2009. Host factors in HPV-related carcinogenesis: Cellular mechanisms controlling HPV infections. Arch Med Res 40:435-442.
21. Gallagher TQ, Derkay CS. 2009. Pharmacotherapy of recurrent respiratory papillomatosis: An expert opinion. Expert Opin Pharmacother 10:645-655.
22. García-Milián R, Hernández H, Panadé L, Rodríguez C, González N, Valenzuela C, Araña MD, Perea SE. 1998. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 118:754-758.
23. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG, zur Hausen. 1983. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80:560-563.
24. Hobbs CG, Birchall MA. 2004. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 12:88-92.
25. Hubbard RA. 2003. Human papillomavirus testing methods. Arch Pathol Lab Med 127:940-945.
26. Jeong WJ, Park SW, Shin M, Lee YJ, Jeon YK, Jung YH, Hah JH, Kwon TK, Song YS, Kim KH, Sung MW. 2009. Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis. Head Neck 31:1095-1101.
27. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B. 1996. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 34:2095-2100.
28. Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, Van Zandt S, Whitt S, Shah K. 1992. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 102:9-13.
29. Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE. 1993. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope 103:416-420.
30. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz. 2001. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276-284.
31. Komloš KF, Kocjan BJ, Košorok P, Luzar B, Meglič L, Potočnik M, Hočevar-Boltežar I, Gale N, Seme K, Poljak M. 2012. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: A study on 574 tissue specimens. J Med Virol 84:1233-1241.
32. Larson DA, Derkay CS. 2010. Epidemiology of recurrent respiratory papillomatosis. APMIS 118:450-454.
33. Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J. 2005. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 58:51-55.
34. Major T, Sziklai I, Czeglédy J, Gáll T, Gergely L, Szarka K. 2008. Follow-up of HPV DNA copy number in Cidofovir therapy of recurrent respiratory papillomatosis. Anticancer Res 28:2169-2174.
35. McClay JE. 2008. Recurrent respiratory papillomatosis. Available at: http://emedicine.medscape.com/article/865758-overview.
36. Molijn A, Kleter B, Quint W, van Doorn LJ. 2005. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32:43-51.
37. Morris BJ. 2005. Cervical human papillomavirus screening by PCR: Advantages of targeting the E6/E7 region. Clin Chem Lab Med 43:1171-1177.
38. Mounts P, Shah KV, Kashima H. 1982. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 79:5425-5429.
39. Orlando C, Pinzani P, Pazzagli M. 1998. Developments in quantitative PCR. Clin Chem Lab Med 36:255-269.
40. Park JS, Leake JF, Sharma BK, Toki T, Kessis TD, Ambros RA, Shah KV. 1991. Variability in ß-globin and HPV DNA amplification by PCR from fixed tissues. Mod Pathol 4:667-670.
41. Puranen M, Yliskoski M, Saarikoski S, Syrjänen K, Syrjänen S. 1996. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 174:694-699.
42. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. 1997. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5 +/GP6+ primer systems. J Clin Microbiol 35:1304-1310.
43. Roberts CC, Swoyer R, Bryan JT, Taddeo FJ. 2011. Comparison of real-time multiplex Human Papillomavirus (HPV) PCR assays with the linear Array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection. J Clin Microbiol 49:1899-1906.
44. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. 1998. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153:1741-1748.
45. Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A. 1986. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 68:795-799.
46. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. 2003. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101:645-652.
47. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. 2007. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465-2472.
48. Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L. 1991. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol 100:479-483.
49. Snijders PJ, van den Brule AJ, Meijer CJ. 2003. The clinical relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J Pathol 201:1-6.
50. Tajadini M, Panjehpour M, Javanmard SH. 2014. Comparison of SYBR Green and TaqMan methods in quantitative real-time polymerase chain reaction analysis of four adenosine receptor subtypes. Adv Biomed Res 3:85.
51. Tseng CJ, Liang CC, Soong YK, Pao CC. 1998. Perinatal transmission of human papillomavirus in infants: Relationship between infection rate and mode of delivery. Obstet Gynecol 91:92-96.
52. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
53. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. 2002. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from thinprep papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 94:2199-2210.
54. Weiss MD, Kashima HK. 1983. Tracheal involvement in laryngeal papillomatosis. Laryngoscope 93:45-48.
55. Weiss D, Koopmann M, Rudack C. 2011. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma. Head Neck 33:856-862.
56. Wong ML, Medrano JF. 2005. Real-time PCR for mRNA quantitation. Biotechniques 39:75-85.
57. Yu D, Chen Y, Wu S, Wang B, Tang YW, Li L. 2012. Simultaneous detection and differentiation of human papillomavirus genotypes 6, 11 16 and 18 by AllGlo quadruplex quantitative PCR. PLoS One 7:e48972.